Search - tctmd.com

Displaying 601 - 620 of 787

Sort: Relevancy | Date

News Conference News EuroPCR 2013

PRAGUE-19 Registry: Bioresorbable Scaffolds an Option for Certain STEMI Patients

Caitlin E. Cox

May 22, 2013

News Conference News EuroPCR 2013

Paclitaxel Delivery Key to PAD Intervention

Caitlin E. Cox

May 22, 2013

News Conference News EuroPCR 2013

Novel Stent Helps Treat Bifurcation Lesions in FIM Registry

Jason Kahn

May 22, 2013

News Industry News

New Data Demonstrate Significant And Sustained Blood Pressure Reduction With Boston Scientific Vessix™ Renal Denervation System

May 22, 2013

News Industry News

For Bifurcation Lesions in Coronary Arteries, Medtronic's Resolute Stent Delivers Strong Long-Term Results

May 22, 2013

News Industry News

Boston Scientific Reports Lotus™ Valve System Met Primary Performance Endpoint in REPRISE II Trial

May 22, 2013

News Industry News

Boston Scientific Promus PREMIER™ And SYNERGY™ Drug-Eluting Stent Systems Provide Exceptional Safety And Efficacy Data

May 22, 2013

Presentation EuroPCR 2013

Mimics Study: Results at 12 Months

Presenter: Stephan H. Duda

May 21, 2013

Presentation EuroPCR 2013

First Report on the Pivotal DESolve Nx Trial: 6-month Clinical and Multimodality Imaging Results

Presenter: Alexandre Abizaid

May 21, 2013

Presentation EuroPCR 2013

4EVER Trial: 1 Year Results

Presenter: Marc Bosiers

May 21, 2013

News Industry News

Positive Patient Outcomes at One Year With Edwards Sapien XT Transcatheter Valve

May 21, 2013

News Industry News

Medtronic Finds TAVI with CoreValve® System Cost Effective for Treating Patients with Severe Aortic Stenosis

May 21, 2013

News Industry News

Medtronic CoreValve ADVANCE Study Demonstrates Low Rates of Mortality and Stroke and Sustained Valve Performance

May 21, 2013

News Industry News

Medtronic Announces Data From Largest Real-World Patient Population Confirm Strong Safety Profile and Clinical Efficacy of Renal Denervation with the Symplicity(TM) System

May 21, 2013

News Conference News EuroPCR 2013

DESolve Nx: Bioresorbable DES Shows Positive Results at 6 Months

Jason Kahn

May 21, 2013

News Industry News

CID SpA Sponsors a Major Symposium at EuroPCR 2013 on Thursday 23rd of May

May 17, 2013

News Industry News

Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013

May 17, 2013

News Industry News

CircuLite® Receives Approval to Begin CE Mark Trial for Synergy® IC Circulatory Support System

May 15, 2013

News Daily News

Post-TAVR Coronary Obstruction Risk Low, Linked to Unfavorable Anatomic Features

L.A. McKeown

May 13, 2013

News Industry News

Elixir Medical Corporation to Announce 6-month Results of the DESolve Fully Bioresorbable Coronary Scaffold System Pivotal Trial at Late Breaking Trial Session of EuroPCR

May 01, 2013

Advertisement

PRAGUE-19 Registry: Bioresorbable Scaffolds an Option for Certain STEMI Patients

Paclitaxel Delivery Key to PAD Intervention

Novel Stent Helps Treat Bifurcation Lesions in FIM Registry

New Data Demonstrate Significant And Sustained Blood Pressure Reduction With Boston Scientific Vessix™ Renal Denervation System

For Bifurcation Lesions in Coronary Arteries, Medtronic's Resolute Stent Delivers Strong Long-Term Results

Boston Scientific Reports Lotus™ Valve System Met Primary Performance Endpoint in REPRISE II Trial

Boston Scientific Promus PREMIER™ And SYNERGY™ Drug-Eluting Stent Systems Provide Exceptional Safety And Efficacy Data

Mimics Study: Results at 12 Months

First Report on the Pivotal DESolve Nx Trial: 6-month Clinical and Multimodality Imaging Results

4EVER Trial: 1 Year Results

Positive Patient Outcomes at One Year With Edwards Sapien XT Transcatheter Valve

Medtronic Finds TAVI with CoreValve® System Cost Effective for Treating Patients with Severe Aortic Stenosis

Medtronic CoreValve ADVANCE Study Demonstrates Low Rates of Mortality and Stroke and Sustained Valve Performance

Medtronic Announces Data From Largest Real-World Patient Population Confirm Strong Safety Profile and Clinical Efficacy of Renal Denervation with the Symplicity(TM) System

DESolve Nx: Bioresorbable DES Shows Positive Results at 6 Months

CID SpA Sponsors a Major Symposium at EuroPCR 2013 on Thursday 23rd of May

Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013

CircuLite® Receives Approval to Begin CE Mark Trial for Synergy® IC Circulatory Support System

Post-TAVR Coronary Obstruction Risk Low, Linked to Unfavorable Anatomic Features

Elixir Medical Corporation to Announce 6-month Results of the DESolve Fully Bioresorbable Coronary Scaffold System Pivotal Trial at Late Breaking Trial Session of EuroPCR

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content